Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7716
+0.0136 (1.79%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Rein Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Selling, General & Admin | 10.51 | 10.9 | 11.42 | 9.96 | 12.68 | 13.86 | 16.72 | 16.33 | 12.92 | 11.36 | 8.33 | 8.62 | 9.33 | 9.68 | 9.63 | 9.9 | 9.45 | 9.6 | 9.61 | 9.44 |
Research & Development | 11.05 | 11.03 | 12.35 | 14.39 | 13.84 | 14.25 | 12.9 | 9.2 | 5.64 | 3.99 | 4.42 | 8.64 | 13.88 | 17.97 | 20.13 | 20.17 | 18.59 | 17.01 | 14.37 | 12.78 |
Other Operating Expenses | - | 28.7 | - | - | - | 37 | - | - | - | 0.93 | - | - | - | - | - | - | - | - | - | - |
Total Operating Expenses | 21.55 | 50.63 | 23.77 | 24.35 | 26.52 | 65.11 | 29.62 | 25.52 | 18.56 | 16.28 | 12.75 | 17.25 | 23.22 | 27.65 | 29.76 | 30.07 | 28.04 | 26.61 | 23.98 | 22.22 |
Operating Income | -50.25 | -50.63 | -60.77 | -61.35 | -63.52 | -65.11 | -29.61 | -25.52 | -18.47 | -16.28 | -13.69 | -18.19 | -24.24 | -27.65 | -29.76 | -30.07 | -28.04 | -26.61 | -23.98 | -22.22 |
Interest Income | - | - | - | - | - | - | - | - | - | - | - | 0.11 | 0.16 | 0.18 | 0.18 | 0.09 | 0.06 | 0.05 | 0.05 | 0.04 |
Other Non-Operating Income (Expense) | -0.67 | 0.05 | 0.34 | 0.65 | 0.7 | 0.69 | 0.36 | 0.3 | 0.4 | 0.54 | 0.93 | 0.78 | 0.57 | 0.32 | 0.05 | 0.12 | 0.42 | 0.44 | -0.36 | -0.42 |
Total Non-Operating Income (Expense) | -0.67 | 0.05 | 0.34 | 0.65 | 0.7 | 0.69 | 0.36 | 0.3 | 0.4 | 0.54 | 0.93 | 0.89 | 0.73 | 0.5 | 0.23 | 0.21 | 0.48 | 0.5 | -0.3 | -0.39 |
Pretax Income | -50.92 | -50.58 | -60.43 | -60.7 | -62.82 | -64.43 | -29.24 | -25.22 | -18.07 | -15.73 | -12.76 | -17.3 | -23.51 | -27.15 | -29.53 | -29.86 | -27.56 | -26.11 | -24.28 | -22.6 |
Provision for Income Taxes | - | -0.71 | - | - | - | -1.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -50.21 | -49.87 | -58.89 | -59.15 | -61.27 | -62.88 | -29.24 | -25.22 | -18.07 | -15.73 | -12.94 | -17.48 | -23.69 | -27.33 | -29.58 | -29.92 | -27.61 | -26.16 | -24.36 | -22.68 |
Net Income to Common | -50.21 | -49.87 | -58.89 | -59.15 | -61.27 | -62.88 | -29.24 | -25.22 | -18.07 | -15.73 | -12.94 | -17.48 | -23.69 | -27.33 | -29.58 | -29.92 | -27.61 | -26.16 | -24.36 | -22.68 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 28 | 25 | 24 | 22 | 21 | 18 | 14 | 9 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 3 |
Shares Outstanding (Diluted) | 28 | 25 | 24 | 22 | 21 | 18 | 14 | 9 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 3 |
Shares Change (YoY) | 29.33% | 41.84% | 72.30% | 138.40% | 284.48% | 290.09% | 200.85% | 106.59% | 21.97% | 1.31% | 0.10% | 0.18% | 0.28% | 2.23% | 18.82% | 42.66% | 85.81% | 154.70% | 142.03% | 121.65% |
EPS (Basic) | -1.90 | -1.96 | -2.94 | -3.00 | -3.17 | -3.51 | -3.15 | -3.28 | -3.22 | -3.42 | -2.84 | -3.84 | -5.21 | -6.02 | -6.51 | -6.51 | -5.95 | -5.89 | -6.60 | -7.80 |
EPS (Diluted) | -1.90 | -1.96 | -2.94 | -3.00 | -3.17 | -3.51 | -3.15 | -3.28 | -3.22 | -3.42 | -2.84 | -3.84 | -5.21 | -6.02 | -6.51 | -6.51 | -5.95 | -5.89 | -6.60 | -7.80 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow | -16.61 | -19.36 | -20.95 | -21.22 | -23.2 | -22.29 | -27.87 | -25.69 | -20.42 | -19.81 | -13.83 | -19.16 | -21.73 | -24.87 | -26.71 | -27.01 | -25.15 | -23.91 | -22.35 | -20.12 |
Free Cash Flow Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.60 | -0.76 | -0.89 | -0.95 | -1.09 | -1.24 | -2.04 | -2.74 | -3.69 | -4.31 | -3.04 | -4.22 | -4.78 | -5.48 | -5.89 | -5.96 | -5.55 | -5.38 | -5.85 | -6.33 |
EBITDA | -50.25 | -50.63 | -60.77 | -61.35 | -63.52 | -65.05 | -29.49 | -25.39 | -18.34 | -16.16 | -13.58 | -18.05 | -24.07 | -27.48 | -29.59 | -29.91 | -27.88 | -26.48 | -23.89 | -22.15 |
EBIT | -50.25 | -50.63 | -60.77 | -61.35 | -63.52 | -65.11 | -29.61 | -25.52 | -18.47 | -16.28 | -13.69 | -18.19 | -24.24 | -27.65 | -29.76 | -30.07 | -28.04 | -26.61 | -23.98 | -22.22 |
Effective Tax Rate | 0.00% | 1.41% | 0.00% | 0.00% | 0.00% | 2.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |